Overall rank by patents
#8,659
of 50,000 tracked assignees
USPTO PatentsView assignee record - 37 granted patents across 7 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
According to USPTO PatentsView, Oxylabs ranks #8,659 of 50,000 tracked US assignees by granted-patent volume, with 37 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R8659 · Foreign Corporation #8,659 · 37 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: OCI Company Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Advanced Micro-fabri… · near
54 score
Bayer Pharma Aktieng… · near
54 score
Halozyme · near
54 score
Heatcraft Refrigerat… · near
54 score
Oxylabs UAB · this assignee
54 score
3D Lighting Innovati… · lowest
7 score
What this shows Oxylabs, UAB stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #8,659 of 50,000; Innovation Score 53.6/100 sits in the top 9% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is OCI Company Ltd. (±0 grants).
Oxylabs, UAB has been granted 37 US utility patents between 2023 and 2025, placing Oxylabs, UAB at #8,659 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a Foreign Corporation, Oxylabs, UAB is one of the more focused assignees in the PatentsView dataset. By volume, Oxylabs sits between OCI Company Ltd. (37 patents, rank #8,654) and Protec Co., Ltd. (37 patents, rank #8,662) - the closest US assignees by grant volume. The composite Innovation Score of 53.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2023 through 2025, with 37 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Oxylabs, UAB's 19.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OCI COMPANY LTD.
37 patents
OPTEX CO., LTD.
37 patents
ORTHOHELIX SURGICAL DESIGNS, INC.
37 patents
Once Innovations, Inc.
37 patents
PACIFIC ENGINEERING CORPORATION
37 patents
PROGRESSIVE CASUALTY INSURANCE COMPANY
37 patents
PROLOGIUM TECHNOLOGY CO., LTD.
37 patents
PROTEC CO., LTD.
37 patents
Oxylabs, UAB
37 patents
What this shows Oxylabs holds 37 patents at rank #8,658, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,658 in granted patent volume.
Other assignees with the most granted patents in Oxylabs's primary technology class.
Two PlainPatent-derived peer sets for Oxylabs, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (54 here).
Oxylabs's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 9% higher than 91% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 18 | 48.6% |
| 2024 | 11 | 29.7% |
| 2025partial year | 8 | 21.6% |
Top 7 of 7 technology areas
Overall rank by patents
#8,659
of 50,000 tracked assignees
53.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.